Evaluation of Plasma and Tissue S100A4 Protein and mRNA Levels as Potential Markers of Metastasis and Prognosis in Clear Cell Renal Cell Carcinoma

New Insights into the Biology of Renal Cell Carcinoma

(2011) Lianjie Li et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

VEGF and prostatic cancer: a systematic review

(2010) Francisco Botelho et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Evaluation of Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-Stage Breast Cancer Patients Treated With Breast-Conserving Therapy

(2010) Meena S. Moran et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

S100A4 and Metastasis

(2009) Kjetil Boye et al.   AMERICAN JOURNAL OF PATHOLOGY

Review: Targeted therapy in renal cancer

(2009) Tanya B. Dorff et al.   Therapeutic Advances in Medical Oncology

Origin of renal cell carcinomas

(2008) Manuel Valladares Ayerbes et al.   Clinical & Translational Oncology

Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies

(2008) Ali-Reza Golshayan et al.   Future Oncology

S100A4: a common mediator of epithelial–mesenchymal transition, fibrosis and regeneration in diseases?

(2008) Mikael Schneider et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer

(2008) Kai-Xing Ai et al.   WORLD JOURNAL OF GASTROENTEROLOGY